• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个晚发性乳腺癌家族中鉴定出一种新的p53种系改变。

A novel p53 germline alteration identified in a late onset breast cancer kindred.

作者信息

Sun X F, Johannsson O, Håkansson S, Sellberg G, Nordenskjöld B, Olsson H, Borg A

机构信息

Department of Oncology, University Hospital, Linköping, Sweden.

出版信息

Oncogene. 1996 Jul 18;13(2):407-11.

PMID:8710380
Abstract

Germline mutations in the p53 tumor suppressor gene are associated with the Li-Fraumeni syndrome, characterized by childhood sarcoma, leukemia and early onset breast cancer and has occasionally been found also in familial breast-ovarian cancer. Most mutations found are of missense type and located in the central region of the gene (exons 5 to 8). In the present study, a germline p53 alteration was identified in a late onset breast cancer family (kindred Lund 5; mean age 58 years) using single stranded conformation polymorphism and sequence analysis. The mutation (a CCG to CTG transition) at codon 82 in exon 4, resulting in a proline to leucine substitution, has not previously been reported and was not present in a control set of 60 healthy individuals. Three of five woman with breast cancer (45, 57 and 65 years) were carriers of the alteration. Loss of heterozygosity at the p53 locus was not seen in the primary tumors of these women, but appeared as a partial loss of the wildtype allele in subsequent recurrent lesions of two gene carriers. The family manifested no linkage to the p53 gene (a two-point LOD-score of -0.41), and has previously also been excluded for linkage to the BRCA1 and BRCA2 loci, as well as being carrier of a BRCA1 germline mutation. Although it seems unlikely that the p53 germline mutation is the major cause of disease predisposition in Lund 5, the data suggest that some p53 alteration may confer a subtle influence on breast cancer development and progression.

摘要

p53肿瘤抑制基因的种系突变与李-佛美尼综合征相关,其特征为儿童期肉瘤、白血病和早发性乳腺癌,偶尔也在家族性乳腺-卵巢癌中发现。发现的大多数突变是错义型,位于基因的中央区域(外显子5至8)。在本研究中,使用单链构象多态性和序列分析,在一个晚发性乳腺癌家族(伦德5家族;平均年龄58岁)中鉴定出一种种系p53改变。外显子4中第82密码子的突变(CCG到CTG的转换)导致脯氨酸被亮氨酸取代,此前未见报道,在60名健康个体的对照组中也不存在。五名乳腺癌女性(45岁、57岁和65岁)中有三名是这种改变的携带者。在这些女性的原发性肿瘤中未观察到p53基因座的杂合性缺失,但在两名基因携带者随后的复发病变中表现为野生型等位基因的部分缺失。该家族与p53基因无连锁关系(两点LOD分数为-0.41),此前也已排除与BRCA1和BRCA2基因座的连锁关系,并且不是BRCA1种系突变的携带者。尽管p53种系突变似乎不太可能是伦德5家族疾病易感性的主要原因,但数据表明,某些p53改变可能对乳腺癌的发生和发展产生微妙影响。

相似文献

1
A novel p53 germline alteration identified in a late onset breast cancer kindred.在一个晚发性乳腺癌家族中鉴定出一种新的p53种系改变。
Oncogene. 1996 Jul 18;13(2):407-11.
2
Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.家族性乳腺癌中特定种系p53内含子突变的频率升高及功能活性增强。
Cancer Res. 2000 Feb 15;60(4):1062-9.
3
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.一名患有新型胚系“新生”TP53突变的患者放疗后肉瘤和乳腺癌的快速发展
Clin Oncol (R Coll Radiol). 2007 Sep;19(7):490-3. doi: 10.1016/j.clon.2007.05.001. Epub 2007 Jun 14.
4
Three germline mutations in the TP53 gene.TP53基因中的三个种系突变。
Hum Mutat. 1997;9(2):157-63. doi: 10.1002/(SICI)1098-1004(1997)9:2<157::AID-HUMU8>3.0.CO;2-6.
5
Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.早发性乳腺癌和卵巢癌家族中肿瘤的种系BRCA1突变及野生型等位基因缺失
Clin Cancer Res. 1995 May;1(5):539-44.
6
Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer.一个遗传性乳腺癌-卵巢癌家族中p53基因的剪接位点突变。
Oncogene. 1994 Jan;9(1):97-102.
7
Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.希腊乳腺癌中低风险个体种系BRCA1和BRCA2基因改变的鉴定——与临床病理数据的相关性
Clin Genet. 2005 Apr;67(4):322-9. doi: 10.1111/j.1399-0004.2004.00400.x.
8
German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.关于遗传性乳腺癌和/或卵巢癌的德国家庭研究:BRCA1基因的种系突变分析
Genes Chromosomes Cancer. 1997 Feb;18(2):126-32.
9
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.来自高危法裔加拿大乳腺癌/卵巢癌家族的乳腺癌病例中ATR序列变异的突变分析与特征描述
BMC Cancer. 2006 Sep 29;6:230. doi: 10.1186/1471-2407-6-230.
10
A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.在一个李-弗劳梅尼综合征家族中,p53基因组DNA发生了2.35 kb的种系缺失,导致寡聚化结构域特异性缺失。
Oncogene. 1994 Nov;9(11):3273-80.

引用本文的文献

1
The Status of p53 Oligomeric and Aggregation States in Cancer.p53 寡聚体和聚集状态在癌症中的地位。
Biomolecules. 2020 Apr 4;10(4):548. doi: 10.3390/biom10040548.
2
Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?错误折叠的肿瘤抑制因子的聚集及类朊病毒特性:癌症是一种朊病毒病吗?
Cold Spring Harb Perspect Biol. 2016 Oct 3;8(10):a023614. doi: 10.1101/cshperspect.a023614.
3
Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.人类癌症中c-Abl和p53的错误折叠、聚集及无序片段
Front Oncol. 2015 Apr 29;5:97. doi: 10.3389/fonc.2015.00097. eCollection 2015.
4
Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.内含子TP53基因种系序列变异改变德国乳腺癌/卵巢癌家族的风险。
Hered Cancer Clin Pract. 2004 Jul 15;2(3):139-45. doi: 10.1186/1897-4287-2-3-139.
5
Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage.p53蛋白第82位脯氨酸的突变会损害其在DNA损伤应答中被Pin1和Chk2激活的能力。
Mol Cell Biol. 2005 Jul;25(13):5380-8. doi: 10.1128/MCB.25.13.5380-5388.2005.
6
Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.儿童肉瘤队列中的种系p53突变:癌症风险的性别差异
Am J Hum Genet. 2003 Apr;72(4):975-83. doi: 10.1086/374567. Epub 2003 Feb 27.
7
BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.BRCA1 引导一种选择性的、依赖 p53 的转录反应,作用于生长停滞和 DNA 修复靶点。
Mol Cell Biol. 2002 Jun;22(12):4280-92. doi: 10.1128/MCB.22.12.4280-4292.2002.
8
Identification of tumour-associated and germ line p53 mutations in canine mammary cancer.犬类乳腺癌中肿瘤相关及种系p53突变的鉴定
Br J Cancer. 1999 Oct;81(3):409-15. doi: 10.1038/sj.bjc.6690709.
9
Identification of an additional negative regulatory region for p53 sequence-specific DNA binding.p53序列特异性DNA结合的一个额外负调控区域的鉴定。
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6079-84. doi: 10.1073/pnas.95.11.6079.
10
Apoptosis by p53: mechanisms, regulation, and clinical implications.p53介导的细胞凋亡:机制、调控及临床意义
Springer Semin Immunopathol. 1998;19(3):345-62. doi: 10.1007/BF00787230.